Science News
from research organizations

Can prostate cancer metastasis be stopped before it starts?

Research team identifies role for particular microRNA

Date:
January 24, 2017
Source:
Roswell Park Cancer Institute
Summary:
Metastasis, or spread of a tumor from the site of origin to additional organs, causes the vast majority of cancer-related deaths, but our understanding of the molecular mechanisms behind metastasis remains limited. A research team has examined the multistep process that leads to metastasis and their work illuminates the role of prostate cancer stem cells that promote tumor growth and metastasis.
Share:
FULL STORY

Metastasis, or spread of a tumor from the site of origin to additional organs, causes the vast majority of cancer-related deaths, but our understanding of the molecular mechanisms behind metastasis remains limited. A research team led by Dean Tang, PhD, Chair of the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute, examined the multistep process that leads to metastasis and their work, which illuminates the role of prostate cancer stem cells that promote tumor growth and metastasis, has been published online ahead of print in the journal Nature Communications.

MicroRNAs (miRNAs) are small genetic molecules that play an essential role in regulating many aspects of cancer cell behavior. When they performed a screening of the miRNA library, Dr. Tang and colleagues found that, surprisingly, only a few miRNAs are commonly deficient or not expressed in prostate cancer stem cells.

The team found that one specific miRNA molecule, miR-141, not only inhibited tumor growth but significantly retarded cancer metastasis in several preclinical prostate cancer models. Taken together with the findings from previous studies reporting the molecule's powerful tumor-suppression capability, the current study demonstrates the potential of miR-141 as an inhibitor of prostate cancer cell invasion and metastasis, and suggests that synthetic miR-141 may be developed as a "replacement" therapeutic to target prostate cancer metastasis.

"This study represents the most comprehensive investigation to date of the role of the miR-141 molecule in regulating prostate cancer stem cells and their role in metastasis," says Dr. Tang, senior author of the new study. "These preliminary findings suggest that miR-141 may suppress the metastatic cascade at an early stage and that the overexpression of miR-141 in prostate cancer cells results in less metastasis. Our observations provide a rationale for developing these targeted miRNA molecules into novel antitumor and antimetastasis replacement therapies."


Story Source:

Materials provided by Roswell Park Cancer Institute. Note: Content may be edited for style and length.


Journal Reference:

  1. Can Liu, Ruifang Liu, Dingxiao Zhang, Qu Deng, Bigang Liu, Hsueh-Ping Chao, Kiera Rycaj, Yoko Takata, Kevin Lin, Yue Lu, Yi Zhong, John Krolewski, Jianjun Shen, Dean G. Tang. MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nature Communications, 2017; 8: 14270 DOI: 10.1038/ncomms14270

Cite This Page:

Roswell Park Cancer Institute. "Can prostate cancer metastasis be stopped before it starts? Research team identifies role for particular microRNA." ScienceDaily. ScienceDaily, 24 January 2017. <www.sciencedaily.com/releases/2017/01/170124125535.htm>.
Roswell Park Cancer Institute. (2017, January 24). Can prostate cancer metastasis be stopped before it starts? Research team identifies role for particular microRNA. ScienceDaily. Retrieved March 26, 2017 from www.sciencedaily.com/releases/2017/01/170124125535.htm
Roswell Park Cancer Institute. "Can prostate cancer metastasis be stopped before it starts? Research team identifies role for particular microRNA." ScienceDaily. www.sciencedaily.com/releases/2017/01/170124125535.htm (accessed March 26, 2017).